liposomal chemotherapy

FDA approves Jazz Pharmaceuticals’ liposomal AML chemotherapy
Drug Delivery Business News
Tue, 08/8/17 - 10:05 am
FDA
Jazz Pharmaceuticals
liposomal chemotherapy
Vyxeos
AML